Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1984 1
1987 1
1989 5
1990 3
1991 2
1992 5
1993 2
1994 4
1995 4
1996 5
1997 2
1998 7
1999 7
2000 10
2001 12
2002 9
2003 13
2004 17
2005 18
2006 8
2007 10
2008 6
2009 12
2010 11
2011 12
2012 15
2013 15
2014 10
2015 13
2016 14
2017 22
2018 18
2019 13
2020 19
2021 13
Text availability
Article attribute
Article type
Publication date

Search Results

306 results
Results by year
Filters applied: . Clear all
Page 1
Timing of high-efficacy therapy for multiple sclerosis: a retrospective observational cohort study.
He A, Merkel B, Brown JWL, Zhovits Ryerson L, Kister I, Malpas CB, Sharmin S, Horakova D, Kubala Havrdova E, Spelman T, Izquierdo G, Eichau S, Trojano M, Lugaresi A, Hupperts R, Sola P, Ferraro D, Lycke J, Grand'Maison F, Prat A, Girard M, Duquette P, Larochelle C, Svenningsson A, Petersen T, Grammond P, Granella F, Van Pesch V, Bergamaschi R, McGuigan C, Coles A, Hillert J, Piehl F, Butzkueven H, Kalincik T; MSBase study group. He A, et al. Among authors: mcguigan c. Lancet Neurol. 2020 Apr;19(4):307-316. doi: 10.1016/S1474-4422(20)30067-3. Epub 2020 Mar 18. Lancet Neurol. 2020. PMID: 32199096
Association of Initial Disease-Modifying Therapy With Later Conversion to Secondary Progressive Multiple Sclerosis.
Brown JWL, Coles A, Horakova D, Havrdova E, Izquierdo G, Prat A, Girard M, Duquette P, Trojano M, Lugaresi A, Bergamaschi R, Grammond P, Alroughani R, Hupperts R, McCombe P, Van Pesch V, Sola P, Ferraro D, Grand'Maison F, Terzi M, Lechner-Scott J, Flechter S, Slee M, Shaygannejad V, Pucci E, Granella F, Jokubaitis V, Willis M, Rice C, Scolding N, Wilkins A, Pearson OR, Ziemssen T, Hutchinson M, Harding K, Jones J, McGuigan C, Butzkueven H, Kalincik T, Robertson N; MSBase Study Group. Brown JWL, et al. Among authors: mcguigan c. JAMA. 2019 Jan 15;321(2):175-187. doi: 10.1001/jama.2018.20588. JAMA. 2019. PMID: 30644981 Free PMC article.
2017 McDonald diagnostic criteria: A review of the evidence.
McNicholas N, Hutchinson M, McGuigan C, Chataway J. McNicholas N, et al. Among authors: mcguigan c. Mult Scler Relat Disord. 2018 Aug;24:48-54. doi: 10.1016/j.msard.2018.05.011. Epub 2018 Jun 21. Mult Scler Relat Disord. 2018. PMID: 29936325 Review.
Interventions for preventing falls in people with multiple sclerosis.
Hayes S, Galvin R, Kennedy C, Finlayson M, McGuigan C, Walsh CD, Coote S. Hayes S, et al. Among authors: mcguigan c. Cochrane Database Syst Rev. 2019 Nov 28;11(11):CD012475. doi: 10.1002/14651858.CD012475.pub2. Cochrane Database Syst Rev. 2019. PMID: 31778221 Free PMC article.
Treatment effectiveness of alemtuzumab compared with natalizumab, fingolimod, and interferon beta in relapsing-remitting multiple sclerosis: a cohort study.
Kalincik T, Brown JWL, Robertson N, Willis M, Scolding N, Rice CM, Wilkins A, Pearson O, Ziemssen T, Hutchinson M, McGuigan C, Jokubaitis V, Spelman T, Horakova D, Havrdova E, Trojano M, Izquierdo G, Lugaresi A, Prat A, Girard M, Duquette P, Grammond P, Alroughani R, Pucci E, Sola P, Hupperts R, Lechner-Scott J, Terzi M, Van Pesch V, Rozsa C, Grand'Maison F, Boz C, Granella F, Slee M, Spitaleri D, Olascoaga J, Bergamaschi R, Verheul F, Vucic S, McCombe P, Hodgkinson S, Sanchez-Menoyo JL, Ampapa R, Simo M, Csepany T, Ramo C, Cristiano E, Barnett M, Butzkueven H, Coles A; MSBase Study Group. Kalincik T, et al. Among authors: mcguigan c. Lancet Neurol. 2017 Apr;16(4):271-281. doi: 10.1016/S1474-4422(17)30007-8. Epub 2017 Feb 11. Lancet Neurol. 2017. PMID: 28209331 Free article.
Radiosynthesis of [18F]-Labelled Pro-Nucleotides (ProTides).
Cavaliere A, Probst KC, Paisey SJ, Marshall C, Dheere AKH, Aigbirhio F, McGuigan C, Westwell AD. Cavaliere A, et al. Among authors: mcguigan c. Molecules. 2020 Feb 6;25(3):704. doi: 10.3390/molecules25030704. Molecules. 2020. PMID: 32041321 Free PMC article.
Cognitive dysfunction in early multiple sclerosis: a review.
McNicholas N, O'Connell K, Yap SM, Killeen RP, Hutchinson M, McGuigan C. McNicholas N, et al. Among authors: mcguigan c. QJM. 2018 Jun 1;111(6):359-364. doi: 10.1093/qjmed/hcx070. QJM. 2018. PMID: 28371862 Review.
Pediatric Parainfectious Encephalitis Associated With COVID-19.
Gaughan M, Connolly S, O'Riordan S, Tubridy N, McGuigan C, Kinsella JA. Gaughan M, et al. Among authors: mcguigan c. Neurology. 2021 Mar 16;96(11):541-544. doi: 10.1212/WNL.0000000000011476. Epub 2021 Jan 4. Neurology. 2021. PMID: 33397771 No abstract available.
Aryloxy phosphoramidate triesters as pro-tides.
Cahard D, McGuigan C, Balzarini J. Cahard D, et al. Among authors: mcguigan c. Mini Rev Med Chem. 2004 May;4(4):371-81. doi: 10.2174/1389557043403936. Mini Rev Med Chem. 2004. PMID: 15134540 Review.
306 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page